CA2475190A1 - Vaccin - Google Patents

Vaccin Download PDF

Info

Publication number
CA2475190A1
CA2475190A1 CA002475190A CA2475190A CA2475190A1 CA 2475190 A1 CA2475190 A1 CA 2475190A1 CA 002475190 A CA002475190 A CA 002475190A CA 2475190 A CA2475190 A CA 2475190A CA 2475190 A1 CA2475190 A1 CA 2475190A1
Authority
CA
Canada
Prior art keywords
bacterium
subject
tsukamurella
rhodococcus
dietzia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002475190A
Other languages
English (en)
Other versions
CA2475190C (fr
Inventor
Oscar Adelmo Bottasso
Graham Mcintyre
Cynthia Ann Stanford
John Lawson Stanford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Biomedica PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Biomedica PLC filed Critical UCL Biomedica PLC
Priority to CA2475190A priority Critical patent/CA2475190C/fr
Publication of CA2475190A1 publication Critical patent/CA2475190A1/fr
Application granted granted Critical
Publication of CA2475190C publication Critical patent/CA2475190C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA2475190A 2004-07-19 2004-07-19 Vaccin Expired - Fee Related CA2475190C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2475190A CA2475190C (fr) 2004-07-19 2004-07-19 Vaccin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2475190A CA2475190C (fr) 2004-07-19 2004-07-19 Vaccin

Publications (2)

Publication Number Publication Date
CA2475190A1 true CA2475190A1 (fr) 2006-01-19
CA2475190C CA2475190C (fr) 2012-11-20

Family

ID=35637000

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2475190A Expired - Fee Related CA2475190C (fr) 2004-07-19 2004-07-19 Vaccin

Country Status (1)

Country Link
CA (1) CA2475190C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109414463A (zh) * 2016-02-25 2019-03-01 托马斯·朱利叶斯·波洛迪 治疗慢性传染性疾病的组合物和方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109414463A (zh) * 2016-02-25 2019-03-01 托马斯·朱利叶斯·波洛迪 治疗慢性传染性疾病的组合物和方法
EP3419638A4 (fr) * 2016-02-25 2019-10-02 Thomas Julius Borody Compositions et procédés de traitement de maladies infectieuses chroniques

Also Published As

Publication number Publication date
CA2475190C (fr) 2012-11-20

Similar Documents

Publication Publication Date Title
JP2017537979A5 (fr)
UA100507C2 (ru) Предупреждение и лечение субклинической формы болезней, вызываемых цирковирусом свиней (pcvd)
BR122017018225A8 (pt) Composição fungicida, seus usos, agente fungicida, método para controlar fungos nocivos fitopatogênicos, e semente resistente a fungos nocivos fitopatogênicos
NZ701724A (en) Compositions comprising a biological control agent and an insecticide
MX2010001903A (es) Flora intestinal y control de peso.
WO2005051323A3 (fr) Analogues de vitamine d pour prevenir et traiter l'obesite
WO2005000217A3 (fr) Polytherapie permettant de traiter la dyslipidemie
PH12014502672A1 (en) Compositions comprising a biological control agent and a fungicide from the group consisting of inhibitors of the respiratory chain at complex i or ii
WO2007022344A3 (fr) Procedes et compositions permettant de prevenir et de traiter les maladies renales
WO2004103297A3 (fr) Polytherapie a base d'acetate de glatiramer et de mitoxantrone destinee au traitement de la sclerose en plaques
EP3318128A3 (fr) Compositions comprenant un agent de contrôle biologique et un fongicide
MX2011006256A (es) Composiciones y procedimientos para controlar enfermedades en animales.
WO2012112340A3 (fr) Procédés et compositions pour le traitement, la réduction ou la prévention de lésions du système nerveux d'animaux
RU2011128689A (ru) Корм для предотвращения и/или лечения заболеваний, вызванных бактериями clostridium, у домашнего скота, и средство против clostridium
WO2006078424A3 (fr) Compositions polyherbales et technique de traitement d'infections virales
WO2006063350A3 (fr) Compositions et methodes destinees a traiter des affections de l'ongle
WO2008150275A3 (fr) Procédés pour empêcher et améliorer la maladie associée au virus du syndrome dysgénésique respiratoire du porc par immunisation contre l'infection du ttv porcin
EP3305305A3 (fr) Compositions à base de silicate et procédés de traitement
WO2005094554A3 (fr) Agents, methodes et traitements therapeutiques
CA2475190A1 (fr) Vaccin
EP4470625A3 (fr) Composition pharmaceutique comprenant une combinaison de probiotique et de prébiotique pour traiter le retard de croissance chez les enfants
WO2005049056A3 (fr) Modulateur immunitaire
KR102159018B1 (ko) 천연 유래 인체 세정용 조성물
WO2007014253A3 (fr) Methode permettant de traiter ou de prevenir la deterioration, les lesions ou les dommages tissulaires causes par l'insuffisance cardiaque congestive
RU2007112409A (ru) Одновременный прием тигициклина и дигоксина

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20190719